TAKEDA PHARMACEUTIC-SP ADR (TAK) Institutional Shareholders
TAKEDA PHARMACEUTIC-SP ADR (TAK) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $1.74B in TAK holdings during the latest filing period.
Capital Research Global Investors is currently the largest disclosed institutional shareholder of TAK tracked by InsiderSet, reporting ownership valued at approximately $353.81M in its March 31, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $326.49M, representing an estimated loss of -7.72% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 65% of the total disclosed TAK value among the investors covered in this analysis. Major shareholders include Capital Research Global Investors, Fmr Llc, Morgan Stanley, and several other long-term asset managers with concentrated positions in TAKEDA PHARMACEUTIC-SP ADR (TAK).
This page ranks the largest institutional TAK shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
359
Total Reported Value
$1.74B
Largest Holder
Capital Research Global Investors
Largest Position
$353.81M
Insider Transactions (90d)
25
Latest Filing Quarter
Q2 2026
New Institutional Positions
68
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Capital Research Global Investors | 0.05% | 19,104,219 | $353,810,136 | $326,491,103 | -$27,319,033 | -7.72% | |
| Fmr Llc | 0.01% | 7,117,486 | $131,815,844 | $121,637,836 | -$10,178,008 | -7.72% | |
| Morgan Stanley | 0.01% | 6,469,600 | $119,817,018 | $110,565,464 | -$9,251,554 | -7.72% | |
| Adage Capital Partners Gp, L.L.C. | 0.18% | 6,424,984 | $118,990,704 | $109,802,977 | -$9,187,727 | -7.72% | |
| Goldman Sachs Group Inc | 0.01% | 5,618,728 | $104,058,841 | $96,024,062 | -$8,034,779 | -7.72% | |
| Brandes Investment Partners, Lp | 0.58% | 4,430,642 | $82,055,682 | $75,719,672 | -$6,336,010 | -7.72% | |
| Blackrock, Inc. | 0.00% | 3,176,421 | $58,827,309 | $54,285,035 | -$4,542,274 | -7.72% | |
| Arrowstreet Capital, Limited Partnership | 0.03% | 3,116,311 | $57,714,080 | $53,257,755 | -$4,456,325 | -7.72% | |
| Renaissance Technologies LLC | Jim Simons | 0.09% | 2,989,100 | $55,358,132 | $51,083,719 | -$4,274,413 | -7.72% |
| Ubs Group Ag | 0.01% | 2,740,229 | $50,749,041 | $46,830,514 | -$3,918,527 | -7.72% | |
| D. E. Shaw & Co., Inc. | 0.04% | 2,602,543 | $48,199,096 | $44,477,460 | -$3,721,636 | -7.72% | |
| First Trust Advisors Lp | 0.03% | 1,971,074 | $36,504,275 | $33,685,655 | -$2,818,620 | -7.72% | |
| Northern Trust Corp | 0.00% | 1,961,038 | $36,318,424 | $33,514,139 | -$2,804,285 | -7.72% | |
| Managed Asset Portfolios, Llc | 3.99% | 1,798,398 | $33,306,334 | $30,734,622 | -$2,571,712 | -7.72% | |
| Envestnet Asset Management Inc | 0.01% | 1,411,927 | $26,148,889 | $24,129,832 | -$2,019,057 | -7.72% | |
| Quantinno Capital Management Lp | 0.04% | 1,289,326 | $23,878,322 | $22,034,581 | -$1,843,741 | -7.72% | |
| Wells Fargo & Company/Mn | 0.00% | 1,136,022 | $21,039,144 | $19,414,616 | -$1,624,528 | -7.72% | |
| Aqr Capital Management Llc | 0.01% | 894,423 | $16,564,709 | $15,285,689 | -$1,279,020 | -7.72% | |
| Capital Wealth Planning, Llc | 0.09% | 886,835 | $16,424,184 | $15,156,010 | -$1,268,174 | -7.72% | |
| Crossmark Global Holdings, Inc. | 0.16% | 783,835 | $12,564,875 | $13,395,740 | +$830,865 | +6.61% | |
| Stifel Financial Corp | 0.01% | 628,550 | $11,640,686 | $10,741,920 | -$898,767 | -7.72% | |
| Citadel Advisors Llc | 0.01% | 624,160 | $11,559,443 | $10,666,894 | -$892,549 | -7.72% | |
| Royal Bank Of Canada | 0.00% | 614,851 | $11,386,000 | $10,507,804 | -$878,196 | -7.71% | |
| Creative Planning | 0.01% | 542,996 | $10,056,285 | $9,279,802 | -$776,483 | -7.72% | |
| Charles Schwab Investment Management Inc | 0.00% | 540,348 | $10,007,245 | $9,234,547 | -$772,698 | -7.72% | |
| American Century Companies Inc | 0.00% | 515,359 | $9,544,449 | $8,807,485 | -$736,964 | -7.72% | |
| Us Bancorp \De\ | 0.01% | 510,225 | $9,449,367 | $8,719,745 | -$729,622 | -7.72% | |
| Focus Partners Wealth | 0.01% | 482,387 | $8,873,154 | $8,243,994 | -$629,160 | -7.09% | |
| Lpl Financial Llc | 0.00% | 474,207 | $8,782,315 | $8,104,198 | -$678,117 | -7.72% | |
| Bleakley Financial Group, Llc | 0.13% | 431,602 | $7,993,269 | $7,376,078 | -$617,191 | -7.72% | |
| Federated Hermes, Inc. | 0.01% | 382,251 | $7,079,289 | $6,532,670 | -$546,619 | -7.72% | |
| Citigroup Inc | 0.00% | 358,174 | $6,633,382 | $6,121,194 | -$512,188 | -7.72% | |
| Vestmark Advisory Solutions, Inc. | 0.07% | 345,822 | $6,404,633 | $5,910,098 | -$494,535 | -7.72% | |
| Qrg Capital Management, Inc. | 0.05% | 372,752 | $5,975,215 | $6,370,332 | +$395,117 | +6.61% | |
| Bank Of America Corp | 0.00% | 319,969 | $5,925,833 | $5,468,270 | -$457,563 | -7.72% | |
| Ethic Inc. | 0.07% | 365,253 | $5,854,998 | $6,242,174 | +$387,176 | +6.61% | |
| Two Sigma Investments, Lp | 0.00% | 311,700 | $5,772,684 | $5,326,953 | -$445,731 | -7.72% | |
| Raymond James Financial Inc | 0.00% | 312,016 | $5,766,691 | $5,332,353 | -$434,338 | -7.53% | |
| Assetmark, Inc | 0.01% | 314,687 | $5,044,432 | $5,378,001 | +$333,569 | +6.61% | |
| Walleye Capital Llc | 0.03% | 260,817 | $4,830,331 | $4,457,363 | -$372,968 | -7.72% | |
| Pathstone Holdings, Llc | 0.02% | 241,293 | $4,468,746 | $4,123,697 | -$345,049 | -7.72% | |
| Clean Yield Group | 1.24% | 238,365 | $4,414,520 | $4,073,658 | -$340,862 | -7.72% | |
| Mariner, Llc | 0.01% | 234,988 | $4,351,162 | $4,015,945 | -$335,217 | -7.70% | |
| Sei Investments Co | 0.00% | 229,943 | $4,258,512 | $3,929,726 | -$328,786 | -7.72% | |
| Trexquant Investment Lp | 0.03% | 229,460 | $4,249,599 | $3,921,471 | -$328,128 | -7.72% | |
| Cetera Investment Advisers | 0.00% | 224,015 | $4,148,765 | $3,828,416 | -$320,349 | -7.72% | |
| Manning & Napier Advisors Llc | 0.06% | 218,977 | $4,055,454 | $3,742,317 | -$313,137 | -7.72% | |
| Ameriprise Financial Inc | 0.00% | 194,037 | $3,593,569 | $3,316,092 | -$277,477 | -7.72% | |
| Bnp Paribas Financial Markets | 0.00% | 190,413 | $3,526,449 | $3,254,158 | -$272,291 | -7.72% | |
| O'Shaughnessy Asset Management, Llc | 0.02% | 185,765 | $3,440,368 | $3,174,724 | -$265,644 | -7.72% |
Frequently asked questions about TAK
Who owns the most TAK stock?
The largest holders of TAK are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for TAKEDA PHARMACEUTIC-SP ADR (TAK).
Is TAK widely held by superinvestors?
Many widely followed stocks like TAK appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly TAK is represented among the institutional managers we track.
What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?
Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.